A Comparison between Single and Double-Dose Intravenous Ketamine Administration in Bipolar Mood Disorder: A Double-Blind Controlled Clinical Trial

A Comparison between Single and Double-Dose Intravenous Ketamine Administration in Bipolar Mood Disorder: A Double-Blind Controlled Clinical Trial

Objectives: As glutamatergic system dysfunction is involved in bipolar depression pathophysiology, the glutamate receptor modulators such as Ketamine have been applied as complementary medication for mood stabilizers. While the treatment is currently just the intravenous injection of a single dose,...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Ali Talaei, Farhad Farid Hoseini, Meisam Mahdavi, Maryam Salehi, Asieh Karimani, Fahimeh Afzaljavan
Format:	Artykuł
Język:	English
Wydane:	Tehran University of Medical Sciences 2023-09-01
Seria:	Iranian Journal of Psychiatry
Hasła przedmiotowe:	Bipolar Disorder Depressive Disorder Ketamine Randomized Controlled Trial
Dostęp online:	https://ijps.tums.ac.ir/index.php/ijps/article/view/2880

Podobne zapisy

The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review
od: Muhammad Youshay Jawad, i wsp.
Wydane: (2023-06-01)

Case report: Adult with bipolar disorder and autism treated with ketamine assisted psychotherapy
od: Christopher P. Harris, i wsp.
Wydane: (2024-02-01)

Intravenous Ketamine for Suicidal Behavior in Severe Depression with Psychotic Features
od: T. V. Pavan Kumar, i wsp.
Wydane: (2025-01-01)

The anti-anhedonic effects of ketamine in the treatment of resistant unipolar and bipolar depression: A systematic review and meta-analysis of current data
od: Thales Marcon Almeida, i wsp.
Wydane: (2024-07-01)

Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression
od: Jian-Qiang Tan, i wsp.
Wydane: (2025-02-01)

An Update on the Efficacy of Single and Serial Intravenous Ketamine Infusions and Esketamine for Bipolar Depression: A Systematic Review and Meta-Analysis
od: Nicolas A. Nunez, i wsp.
Wydane: (2023-12-01)

Mathematical modelling, forecasting and telemonitoring of mood in bipolar disorder
od: Moore, PJ
Wydane: (2014)

NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial
od: Andrew Nierenberg, i wsp.
Wydane: (2023-08-01)

Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
od: Alina Wilkowska, i wsp.
Wydane: (2022-02-01)

Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study
od: Wei Zheng, i wsp.
Wydane: (2020-11-01)

The broad bipolar phenotype: sampling the experience of mood, stress and mental imagery
od: Malik, A
Wydane: (2012)

Ketamine: A New Antidepressant?
od: Feride Karacaer
Wydane: (2015-03-01)

Efficacy of intravenous esketamine in reducing suicidal ideation and major depressive symptoms: A real-world evidence study
od: Tiago Gil, i wsp.
Wydane: (2024-07-01)

Ketamine As A New Therapeutic Option For The Management Of Mental Disorders
od: M. Turki, i wsp.
Wydane: (2022-06-01)

A prospective open-label study to evaluate the effectiveness of intravenous ketamine as an adjunct in treating severe depression
od: Pavan Kumar Thatisetti Venkata, i wsp.
Wydane: (2024-04-01)

Ketamine induced acute systolic heart failure
od: Fares Saliba, i wsp.
Wydane: (2024-04-01)

Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management
od: Alina Wilkowska, i wsp.
Wydane: (2023-12-01)

Therapeutic monitoring of mood stabilizers in bipolar disorder
od: D. Falfel, i wsp.
Wydane: (2021-04-01)

Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
od: Giovanni Martinotti, i wsp.
Wydane: (2021-06-01)

Nonlinear time-series approaches in characterizing mood stability and mood instability in bipolar disorder.
od: Bonsall, M, i wsp.
Wydane: (2012)

Efficacy of Intravenous Low-Dose Ketamine for Prevention of Post-Spinal Anesthesia Shivering in Cesarean Section: A Double-Blind, Randomized Controlled Study
od: Khemraj Meena, i wsp.
Wydane: (2024-08-01)

Guidelines for ketamine use in clinical psychiatry practice
od: Luke A. Jelen, i wsp.
Wydane: (2024-05-01)

Safety of Repeated Administration of Parenteral Ketamine for Depression
od: David Feifel, i wsp.
Wydane: (2020-07-01)

Bipolar /
od: Lake, C. Raymond, author 656115, i wsp.
Wydane: (2021)

Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression
od: Jakub Słupski, i wsp.
Wydane: (2020-12-01)

Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis
od: Alessandro Rodolico, i wsp.
Wydane: (2024-02-01)

Mood stability versus mood instability in bipolar disorder: a possible role for emotional mental imagery
od: Holmes, E, i wsp.
Wydane: (2011)

Case series of intravenous ketamine infusion in patients with suicidal thought
od: Pankaj Sharma, i wsp.
Wydane: (2023-01-01)

Bipolar disorder and peripartum mood episodes: Epidemiology and clinical correlates
od: E. Aragno, i wsp.
Wydane: (2021-04-01)

Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial
od: Ahmad Zolghadriha, i wsp.
Wydane: (2024-05-01)

Behavioural Variant of Frontotemporal Dementia or Mood Disorder?
od: B. Mesquita, i wsp.
Wydane: (2022-06-01)

Neurological Soft Signs in Type I Bipolar Disorder and Bipolar Spectrum Patients and Their Unaffected First‐Degree Relatives: A Cross‐Sectional Study
od: Seyed Saeed Sadr, i wsp.
Wydane: (2025-01-01)

Adverse drug reactions in the bipolar disorder patients treated with mood stabilizers
od: Bhausaheb Baliram Jankar, i wsp.
Wydane: (2024-01-01)

Myasthenia and bipolar disorder: a case report and review of literature
od: B. Emna, i wsp.
Wydane: (2022-06-01)

Epilepsy and Mood Disorders
od: Sermin Kesebir, i wsp.
Wydane: (2012-03-01)

Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant depression: a naturalistic feasibility study
od: Katelyn Halpape, i wsp.
Wydane: (2025-01-01)

Intravenous ketamine therapy in a patient with a treatment-resistant major depression
od: M Liebrenz, i wsp.
Wydane: (2007-04-01)

Dealing with bipolar disorder in general practice
od: D. Rodseth
Wydane: (2011-11-01)

Impulsivity in remitted bipolar disorder
od: I. Lajmi, i wsp.
Wydane: (2021-04-01)

Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions
od: Anya Ragnhildstveit, i wsp.
Wydane: (2022-03-01)